• Breaking News

    Friday, May 7, 2021

    Home Unlabelled Stock Market - This terrible week is over and guess what...

    Stock Market - This terrible week is over and guess what...

    May 07, 2021

    Stock Market - This terrible week is over and guess what...

    This terrible week is over and guess what...

    Posted: 07 May 2021 01:35 PM PDT

    Sad For DogeCoin Founder Selling All The Coins Just Enough To Buy The Old Honda Civic, DogeCoin Now Has Twice As Much Capitalization As Honda.

    Posted: 07 May 2021 03:37 AM PDT

    When stock market CLOSES... And you have to focus on your Life more than the prices

    Posted: 07 May 2021 01:21 PM PDT

    Bag holding Eeyore somewhere in the Hundred Acre Wood

    Posted: 07 May 2021 10:33 AM PDT

    Sell in May and go away.. Then come back.. This weeks market recap

    Posted: 07 May 2021 01:42 PM PDT

    Market Heatmap - 5/7

    Posted: 07 May 2021 12:18 PM PDT

    US Chamber of Commerce calls for ending extra unemployment benefits after disappointing jobs report

    Posted: 07 May 2021 09:26 AM PDT

    "The disappointing jobs report makes it clear that paying people not to work is dampening what should be a stronger jobs market," U.S. Chamber of Commerce Chief Policy Officer Neil Bradley said in a statement on Friday. "One step policymakers should take now is ending the $300 weekly supplemental unemployment benefit. Based on the Chamber's analysis, the $300 benefit results in approximately one in four recipients taking home more in unemployment than they earned working."

    The U.S. economy added much fewer jobs than expected in April, with employers increasing their payrolls by 266,000 jobs, well below the 1 million that economists expected, according to consensus data compiled by Bloomberg. The economy is still 8.2 million jobs short of its February 2020 pre-pandemic levels.

    Source

    submitted by /u/LogicX64
    [link] [comments]

    One sad month so far

    Posted: 07 May 2021 05:35 AM PDT

    Is there a term for why I’m describing?

    Posted: 07 May 2021 07:29 PM PDT

    Let's say I buy 10 shares of company X at $1 each.

    Now let's say 3 months after I buy those shares, the price of each share reaches $10.

    So my unrealised profit is $100.

    So let's assume I sell half of my shares, so now I have 5 shares and $50.

    Say 3 months after that the price of each share reaches $20.

    I sell my remaining 5 shares and get $100.

    In the end I end up with $150.

    But, if I held and sold all my shares at the peak, I would've made $200.

    So is there a word or term to describe that I only made 75% of what I could've made if I had sold at the peak only?

    submitted by /u/Djok911710
    [link] [comments]

    VIX Volatility Index - Epic Market Crash Predicted?

    Posted: 07 May 2021 07:34 AM PDT

    For those that don't know the VIX Volatility Index measures the expectation of stock market volatility over the next 30 days implied by S&P 500 index options. Look at the chart on that link, it shows the 2008 crash and the pandemic last year as massive spikes in anticipated volatility.

    Now take a look at the options on VIX expiring May 19th. That's an insane level of hedging on expected volatility.

    Can anyone shed some light on this for me? I mean people are making massive bets on volatility reaching 150, even in 2008 the peak volatility was only 80 on this index. What the hell is happening this month?

    submitted by /u/Zeazaw
    [link] [comments]

    Started investing in February2021. I was frustrated by some heavy red from the start. Little did I know the gains that were about to come. Feels good. 80% stocks 20% ETH.

    Posted: 07 May 2021 07:37 AM PDT

    The entire market going up this month, new tops and fresh bottoms

    Posted: 07 May 2021 02:48 PM PDT

    Lotta people looking at statistics for this month and the negative press Biden gets for anything he does. However, it won't be commodities, bitcoin, or gold alone. It will be everything, including stonks in general. If you had great gains last month but were unsure why great earnings resulted in declines in prices - watch this month and pay attention, volatility will go up because we will be testing ATHs on everything.

    Fear will make sure volatility keeps up but greed will ensure ATHs

    Gold has tested 2k right? This year we will see gold test limits never seen before, the highest limits.

    Silver, Lumber, Steel, Uranium, Samarium, Soy, you name it. Going up.

    Real estate? Going up!

    Vaccination rates? Going up! New/active cases of corona? Going up! We will need new vaccines.

    Defensive, Growth, Value, it will all go up

    Enjoy the rest of this month!

    submitted by /u/ViralInfectious
    [link] [comments]

    Banks Continue To "Block" Bitcoin, CITIC Bank Says It Prohibits The Use Of Accounts For Bitcoin Transactions

    Posted: 07 May 2021 02:22 PM PDT

    Tesla sitting right at 666...seems ominous

    Posted: 07 May 2021 02:32 AM PDT

    Wk 7 1k portfolio

    Posted: 07 May 2021 02:58 PM PDT

    S&P 500 visual summary: May 7

    Posted: 07 May 2021 01:33 PM PDT

    Unsolicited advice from a financial advisor for new investors

    Posted: 07 May 2021 06:45 AM PDT

    I love seeing people get excited about the stock market and investing for the first time, but it pains me to see those same people lose crazy amounts of money because they're day trading in individual stocks they don't actually know much about...

    The best advice I can give to young, new investors is to IGNORE the trends, and do NOT invest in individual stocks at first.

    This advice may not be exciting or sexy, and it may seem pretty vanilla, but one of the best decisions you can make as a young investor is to simply invest your money in a low-cost ETF that tracks an index like the S&P 500 or Russell 2000.

    The benefit of this strategy is that you'll immediately receive diversification across multiple sectors of the economy (which is extremely important when building a portfolio), you'll be invested in quality companies that have inherent value and aren't just propped up by market trends, and you won't incur the kinds of costs or capital gains taxes that come with actively managed funds.

    You may not see massive gains in the short term, and you'll definitely see volatility, but if you want to build up as much wealth over the long-term as possible and want to have the peace of mind of knowing without a doubt that your investments will eventually recover, this is one of the best ways to get started, especially if you're only able to invest $25 or $50 a week/month.

    submitted by /u/Item_Economy
    [link] [comments]

    Bitfarms uplisting on the NASDAQ exchange is being finalized

    Posted: 07 May 2021 03:08 PM PDT

    After months of standby and a tedious process, Bitfarms has completed requirements to be listed on the NASDAQ. Availability on RobinHood and other platforms is imminent.

    Bitfarms uplisting on the NASDAQ exchange is being finalized - DecentraNews

    On April 24th we were talking about how massively undervalued this stock was compared to its American peers. And the market is finally realizing it. We were early. Bitcoin is up 25% or $1.40 today, ending the trading session at $7.60 CAD on the TSX exchange.

    Being located in Quebec, they have an edge on electricity costs, but also on sustainable energy use, their power-hungry enterprise is powered by Quebec's almost 100% hydroelectric grid. Which is 100% renewable.

    You should probably get in if you can, before the Nasdaq uplisting and Robinhooders get all over it.

    submitted by /u/NikoLetubeur
    [link] [comments]

    Chargepoint entry price?

    Posted: 07 May 2021 02:05 PM PDT

    Hey Guys,

    I love the company Chargepoint... I was just wondering what the best entry price into is?

    I only just noticed the company, and the market is all over the place at the moment.

    I only started investing in Jan 2021, when the market was almost at its peak. So most of the companies I have already invested in, I did at their all time highs....

    Arkk - 142

    NVTA - 40

    BE - 40

    Tilray - 30 !!

    etc etc.

    I have since just spent time reducing my average price on all these positions... So i don't really want to do that for chargepoint as well,

    so any advice is welcome. :)

    thanks

    P.S - I hope this post doesn't get removed

    submitted by /u/updawg_1992_SL
    [link] [comments]

    Awarded $11 Billion In 2020, Elon Musk Plans To Receive Another Tens Of Billion This Year

    Posted: 07 May 2021 05:38 PM PDT

    Here is a Market Recap for today Friday, May 7, 2021

    Posted: 07 May 2021 01:51 PM PDT

    PsychoMarket Recap - Friday, May 7, 2021

    Keeping up with current volatility, the stock market jumped up today to new records, with the S&P 500 (SPY) and Dow Jones (DIA) reaching fresh intraday records, driven higher by a swift reversal to the upside by tech-stocks. Market participants continue to digest corporate earnings reports and the disappointing April Jobs Report, which showed the US economy added fewer jobs than expected even despite the easing of social distancing guidelines.

    The Labor Department showed that the US only brought back 266,000 jobs for the month of April, far less than the gain of at least 1 million that was originally expected and a big deceleration from the numbers seen in March. The unemployment rate unexpectedly increased to 6.1%, widening further from its pre-pandemic level of 3.5%.

    This new economic data serves to bolster the argument that monetary officials have been making that, despite significant progress, the labor market remains well below pre-pandemic levels and that more support from the Central Bank is needed to bolster the momentum of the recovery. Altogether, the US remains roughly 8.2 million jobs short compared to pre-pandemic levels, and both the unemployment rate and labor force participation remains well below January 2020.

    In the past, Federal Reserve Chair Jerome Powell has suggested the Central Bank wants to see a "string" of strong labor market gains totalling more than 1 million before any adjustment to the current policy is made. With the April report disappointing, it appeared the labor market remains far below the Central Bank targets, meaning it is unlikely to change its current accommodative policy anytime soon.

    Seema Shah, Chief Strategist at Principal Global Investors said, "The smaller rise in payrolls should at least assuage some concerns around the Fed policy outlook. As we have heard several times in recent days, even a very strong jobs number wouldn't have caused the committee to formally discuss changing the pace of bond purchases, so today's number certainly won't be giving the Fed cause for concern. They will be in no rush to bring forward tapering plans."

    Highlights

    • The weak April jobs report catalyzed a rebound in technology names Friday morning, with the disappointing data easing fears that the Federal Reserve will adjust their policies in the near-term.
    • Moderna (MRNA) posted a profit for the first time for Q1 2021, bolstered by revenue brought from the coronavirus vaccine.
    • ROKU and Square (SQ) both gapped up today after blowing past analyst estimates in their earnings report.
    • Amid mounting pressure from antitrust regulators, e-commerce giant Alibaba Group offloaded its entire stake in a real estate trading platform, retreating from a new business for which it once held high hopes.
    • IBM introduced what it says is the world's first 2-nanometer chip making technology. The technology could be as much as 45% faster than the mainstream 7-nanometer chips in many of today's laptops and phones and up to 75% more power efficient, the company said. Read more here.
    • Pfizer (PFE) and BioNTech (BNTX) submitted an application with the US FDA to approve use of their coronavirus vaccine for individuals 16 and older
    • **Please note that current stock price was written premarket and does not reflect intraday movement*\*
    • AutoZone (AZO) target raised by UBS Group from $1415 to $1700 at Buy. Stock currently around $1488
    • Adient (ADNT) target raised by Deutshce Bank from $58 to $63 at Buy. Stock currently around $48
    • Avalara (AVLR) target raised by Morgan Stanley from $170 to $175 at Overweight. Stock currently around $124
    • BioCryst Pharmaceuticals (BCRX) target raised by Barclays from $13 to $20 at Overweight
    • BILL target raised by KeyCorp from $165 to $175 at Overweight. Stock currently around $130
    • Builders FirstSource (BLDR) target raised by Barclays from $57 to $68 at Overweight. Stock currently around $52
    • Costco (COST) target raised by Raymond James from $375 to $410 at Outperform. Stock currently around $382
    • Datadog (DDOG) with two very bullish price target raises. Stock currently around $71
      • Monness Crespi & Hardt from $100 to $103 at Buy
      • Needham & Co from $141 to $150 at Buy
    • Diodes (DIOD) target raised by Cowen from $95 to $100 at Outperform. Stock currently around $72
    • Expedia Group (EXPE) with three target raises. Stock currently around $165
      • Credit Suisse from $168 to $198 at Outperform
      • JPM Securities from $185 to $195
      • Wells Fargo from $215 to $235
    • FMC target raised by KeyCorp from $133 to $136 at Overweight. Stock currently around $117
    • Floor & Decor (FND) target raised by Barclays from $110 to $125 at Overweight. Stock currently around $113
    • Health Catalyst (HCAT) with three target raises. Stock currently around $51.50
      • Cantor Fitzgerald from $52 to $60
      • SVB Leerink from $53 to $59
      • Raymond James from $56 to $63
    • Moderna (MRNA) with two target raises. Stock currently around $160
      • Barclays from $178 to $194 at Overweight
      • Goldman Sachs from $206 to $228 at Buy
    • Planet Fitness (PLNT) target raised by Jefferies Financial Group from $95 to $100 at Buy. Stock currently around $80
    • Square (SQ) with two target raises after blowout earnings report. Stock currently around $235
      • JP Morgan from $250 to $300 at Overweight
      • Credit Suisse from $290 to $300 at Outperform
    • Tapestry (TPR) target raised by Robert W Baird from $45 to $54 at Outperform. Stock currently around $47

    "It is in your moments of decision that your destiny is shaped." - Tony Robbins

    submitted by /u/psychotrader00
    [link] [comments]

    3D Systems continues push into bioprinting with Allevi deal.

    Posted: 07 May 2021 02:23 PM PDT

    The research community is critical to developing breakthrough innovations in regenerative medicine. 3D Systems, with the addition of Allevi Inc, is now able to provide a robust set of Allevi by 3D Systems bioprinting solutions to researchers and industry giants in hundreds of labs globally.

    Allevi is a leading innovator in the bioprinting space with an exclusive focus on the research and development community. Leading laboratories leverage Allevi's portfolio of hardware, biomaterials and software to design, engineer and build solutions for tissue engineering, organ-on-a-chip research, pharmaceutical validation, biomaterial development, and regenerative medicine.

    Allevi desktop 3D bioprinters are among the most versatile, powerful and easy-to-use bioprinters on the market. Customers also have access to a wide range of biomaterials—bioinks, bioink additives, cells, reagents and consumables—as well as an intuitive software interface.

    In the medical field, 3D Sytems has delivered additive manufacturing solutions to the healthcare community for more than 30 years. Having produced more than 2,000,000 serial component medical devices and 140,000 patient-specific surgical cases, the company is now scaling the production of bioprinted clinical applications. This technology will elevate patient care through various clinical applications ranging from acellular bioresorbable devices to functionalized solid organs for transplantation.

    Before bioprinter hardware manufacturer Allevi, 3D Systems had already entered the bioprinting services market. Together with United Therapeutics Corporation and its organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC, the company achieved significant progress in the development of next-generation bioprinting solutions for lung scaffolds that are capable of full size, vascularized, rapid, micron-level printing. 3D Systems' capabilities as a technology innovator, spanning hardware, software, and materials science, combined with United Therapeutics' renowned expertise in regenerative medicine has enabled advances in lung modeling, 3D printing, as well as material formulation and material handling to yield significant capabilities in bioprinters and biomaterials for the eventual production of transplantable organs. To meet the evolving needs of the clinical and R&D communities, 3D Systems continues to push technologies to facilitate advanced application development. The Print to Perfusion process enables 3D printing of high-resolution scaffolds, which can be perfused with living cells to create tissues. The ability to print large, vascularized, highly detailed hydrogel scaffolds at rapid speeds is opening new opportunities for a range of tissue applications. In addition, we are developing bioprinting solutions that are both commercially viable and scalable from prototype to production.

    Link: https://www.3dprintingmedia.network/3d-systems-continues-push-into-bioprinting-with-allevi-partnership/

    submitted by /u/No_Cryptographer6183
    [link] [comments]

    I valued MSFT at $ 244 and it is still good

    Posted: 07 May 2021 01:33 PM PDT

    My full report: https://datastudio.google.com/s/pO1DcwglE7w

    In short, they are still growing on most segments, the CEO does smart acquisitions (usually at a bit of a premium).

    ​

    --Next Moves: Healthcare Applications--

    ​

    The healthcare sector is characterized by massive bureaucracy and opportunities for growth. It is one of the rare sectors where real future growth is possible by innovation. Microsoft has established itself as a corporate and industry suite, but now it seems that they are taking their whole Eco-system and moving on the healthcare industry.

    This is pure speculation, but it can be one of the boldest moves yet, as healthcare facilities, operations, education, training, quality control are large complex systems that can benefit from the tools and services that the company offers.

    We have seen Microsoft positioning for a certain client type and taking over most of their business. As the opportunities for growth in the corporate sector decrease, Microsoft might just turn to one of the most complex industries with high barriers to entry and large upfront investment costs.

    On 11 April 2021 they entered into an agreement to acquire Nuance Communications for $ 56 per share, or $19.7 Billion. Nuance is a cloud and artificial intelligence ("AI") software provider with healthcare and enterprise AI experience, and the acquisition will build on our industry-specific cloud offerings. This is effectively their foot in the door to the healthcare industry.

    ​

    --Value--

    I think that the company is trading around its intrinsic value, with potential for growth in the future. There is inflation related market risk that can push down value, but with proper management and pricing flexibility they can at least sustain current value levels.

    Microsoft solidified the cloud for the corporate & business sector, and decreased the risk of their sales by adopting a continuous subscription model for most of their services.

    Their business model seems to be growth trough innovation as they are positioning themselves precisely in segments where innovation is lacking and are integrating those segments within their high-barrier to entry, complex systems.

    submitted by /u/ThinkValue2021
    [link] [comments]

    WHAT YOU APES THINK?

    Posted: 07 May 2021 07:29 PM PDT
    Read more
    at

    No comments:

    Post a Comment